Fall in HDL-cholesterol in diabetic patients treated with micronised fenofibrate therapy

被引：0
|
作者：
Hulme, SA
Furlong, NJ
Obrien, SV
Hardy, KJ
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2032
引用
收藏
页码：A495 / A495
页数：1
相关论文
共 50 条
  • [31] Therapy and clinical trials: HDL-cholesterol and niacin therapy - past, present, and future
    Virani, Salim S.
    Ballantyne, Christie M.
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (02) : 165 - 166
  • [32] TOTAL-CHOLESTEROL AND HDL-CHOLESTEROL IN PATIENTS WITH SILENT AND SYMPTOMATIC MYOCARDIAL ISCHEMIA
    BARTH, JD
    AENGEVAEREN, WR
    ARENDS, H
    ARTERIOSCLEROSIS, 1988, 8 (05): : A583 - A583
  • [33] Treating patients with low HDL-cholesterol: choices, issues and opportunities
    Watts, GF
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (03): : 118 - 122
  • [34] HDL-cholesterol values in hypertensive patients in reference to the intervention type
    Conic, S.
    Slovic, S.
    Pucar, M.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 89S - 90S
  • [35] RISK FACTORS HDL-cholesterol levels and mortality in patients with ESRD
    Vaziri, Nosratola D.
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (11) : 621 - 623
  • [36] THE PLASMA HDL-SUBFRACTION PROFILE IN HYPERTENSIVE PATIENTS WITH HIGH HDL-CHOLESTEROL LEVELS
    Triantafyllidi, Helen
    Benas, Dimitrios
    Tellis, Constantinos
    Tselepis, Alexandros
    Iliodromitis, Efstathios
    JOURNAL OF HYPERTENSION, 2023, 41 : E138 - E139
  • [37] HDL-Cholesterol Determines Nocturnal Blood Pressure Decline in the Elderly with Treated Hypertension
    Harada, Kazumasa
    Kariya, Taro
    Tanaka, Aya
    Toba, Ayumi
    Imai, Yasuko
    Aoyama, Rie
    Sugie, Masamitsu
    Yokota, Hajime
    Ishiyama, Taizo
    Tsuboko, Yusuke
    Fujimoto, Hajime
    Takeda, Kazuhiro
    CIRCULATION, 2011, 124 (21)
  • [38] Low HDL-cholesterol: common and under-treated, but which drug to use?
    Wierzbicki, Anthony S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (10) : 1149 - 1153
  • [39] Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: A prospective study in surgical patients
    DelgadoRodriguez, M
    MedinaCuadros, M
    MartinezGallego, G
    SilleroArenas, M
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1997, 18 (01): : 9 - 18
  • [40] Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin
    Krikken, J. A.
    Waanders, F.
    Dallinga-Thie, G. M.
    Dikkeschei, L. D.
    Vogt, L.
    Navis, G. J.
    Dullaart, R. P. F.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (05) : 497 - 504
12345